Going beyond efficacy: supportive care and addressing the toxicity of systemic therapy

Going beyond efficacy: supportive care and addressing the toxicity of systemic therapy

S3 CURRENT ONCOLOGY—VOLUME 15, SUPPLEMENT 1 Copyright © 2008 Multimed Inc. Significant advances in oncology have been made in recent decades. In general, the mortality rates associated with most cancers are now decreasing, and a significant number of new treatments are now available for cancer patients. As oncologists use more complex treatments to cure patients or to prolong their survival, re...

Population health systems: going beyond integrated care

Comparison of Complications and length of Hospitalization in management of Stevens-Johnson Syndrome with Systemic Steroid or Supportive Care

ABSTRACT Stevens-Johnson syndrome (SJS) is a serious acute self limited emergency in dermatology with considerable morbidity and mortality, Its specific therapy with systemic steroids has been the matter of challenge and controversy in the past 4 decades. The purpose of this study was comparing of complications and the length of hospitalization between those treated with steroids and supporti...

Going beyond current ideas about the cascade of HIV care

When initiated and taken every day exactly as prescribed and directed, HIV treatment(ART) can greatly reduce the amount of HIV in the blood (viral load), allowing the immune system to begin the process of gradually repairing itself. As the use of ART continues, the amount of HIV in the blood eventually falls very low—below the level at which it can accurately be counted with routine tests. This...

Prioritisation of specialist health care services: going beyond the evidence

Materials and methods A Prioritisation Panel representing a wide range of stakeholders was convened. A master list of services was achieved through matching against criteria (including high cost individual care, growth or implementation that exceeded an incremental cost of £50,000, uncertainty about evidence or ability to benefit) for evidence and prioritisation. Condition-Treatment pairs were ...